DAVID
FRAGUAS HERRÁEZ
Profesor asociado
Hospital General Universitario Gregorio Marañón
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (69)
2024
-
School bullying in children and adolescents with neurodevelopmental and psychiatric conditions: a systematic review and meta-analysis
The Lancet Child and Adolescent Health, Vol. 8, Núm. 2, pp. 122-134
2023
-
Aripiprazole for the treatment of schizophrenia: Recommendations of a panel of Spanish experts on its use in clinical practice
International Journal of Psychiatry in Clinical Practice, Vol. 27, Núm. 1, pp. 82-91
-
Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study
Schizophrenia Bulletin, Vol. 49, Núm. 5, pp. 1269-1280
-
The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case–control study
Social Psychiatry and Psychiatric Epidemiology, Vol. 58, Núm. 10, pp. 1573-1580
2022
-
Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis
Molecular Autism, Vol. 13, Núm. 1
-
The impact of cognitive reserve, cognition and clinical symptoms on psychosocial functioning in first-episode psychoses
Psychological Medicine, Vol. 52, Núm. 3, pp. 526-537
2021
-
First episode psychosis longitudinal cohort studies: The CIBERSAM FEP cohort
European Neuropsychopharmacology
-
Fronto-parietal gray matter volume loss is associated with decreased working memory performance in adolescents with a first episode of psychosis
Journal of Clinical Medicine, Vol. 10, Núm. 17
-
Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion
Molecular Psychiatry, Vol. 26, Núm. 8, pp. 4496-4510
-
Humanization in mental health plans in Spain
Revista de Psiquiatria y Salud Mental
-
The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study
Translational Psychiatry, Vol. 11, Núm. 1
-
The role of depression in the prediction of a “late” remission in first-episode psychosis: An analysis of the OPTiMiSE study
Schizophrenia Research, Vol. 231, pp. 100-107
-
The role of premorbid iq and age of onset as useful predictors of clinical, functional outcomes, and recovery of individuals with a first episode of psychosis
Journal of Clinical Medicine, Vol. 10, Núm. 11
-
The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis
Psychopharmacology, Vol. 238, Núm. 3, pp. 665-676
2020
-
Birth weight and antipsychotic induced weight gain: A prenatal programming approach in the PEPs study
Schizophrenia Research, Vol. 218, pp. 292-294
-
Placebo response in pharmacological and dietary supplement trials of autism spectrum disorder (ASD): Systematic review and meta-regression analysis
Molecular Autism, Vol. 11, Núm. 1
-
The Positive and Negative Syndrome Scale for Schizophrenia Autism Severity Scale (PAUSS) in young people with autism and schizophrenia
Revista de Psiquiatria y Salud Mental, Vol. 13, Núm. 3, pp. 118-130
-
Using common genetic variation to examine phenotypic expression and risk prediction in 22q11.2 deletion syndrome
Nature Medicine, Vol. 26, Núm. 12, pp. 1912-1918
2019
-
Neuroanatomical deficits shared by youth with autism spectrum disorders and psychotic disorders
Human Brain Mapping, Vol. 40, Núm. 5, pp. 1643-1653
-
Oxidative stress and inflammation in first-episode psychosis: A Systematic Review and Meta-analysis
Schizophrenia Bulletin, Vol. 45, Núm. 4, pp. 742-751